Pharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the
Pharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at preventing bleeding among adults with moderate […]
The post US approves gene therapy treatment for hemophilia appeared first on Insider Paper.
https://insiderpaper.com/us-approves-gene-therapy-treatment-for-hemophilia/
Comments
0 comment